nach oben

Archives of Gynecology and Obstetrics

Erschienen in:

23.08.2018 | Gynecologic Endocrinology and Reproductive Medicine

The risk of birth defects among children born after vitrified blastocyst transfers and those born after fresh and vitrified cleavage-stage embryo transfers

verfasst von: Qianqian Zhu, Ningling Wang, Bian Wang, Yun Wang, Yanping Kuang

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 4/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To explore the risk of birth defects among children born after vitrified blastocyst transfers and those born after fresh and vitrified cleavage-stage embryo transfers.

Methods

A retrospective cohort study was conducted including infants born after fresh and vitrified day 3 embryo transfers and those born after vitrified day 5 or 6 blastocyst transfers from January 2005 through December 2016. The outcome measures included any birth defect, multiple birth defects and 13 individual categories of birth defects.

Results

Any birth defect occurred in 1.15% of infants born after fresh day 3 embryo transfers, 1.75% of infants born after vitrified day 3 embryo transfers, 1.60% of infants born after vitrified day 5 blastocyst transfers and 1.10% of infants born after vitrified day 6 blastocyst transfers. There was no difference in the risk of birth defects between vitrified blastocyst-stage transfers and vitrified cleavage-stage transfers (including day 5 vs. day 3 and day 6 vs. day 3) among all births or in only singletons or twins. For infants born after cleavage-stage embryo transfers at day 3, there was no difference in the risk of birth defects between fresh embryo transfers and vitrified embryo transfers among all births or in only singletons or twins.

Conclusions

Transfer of vitrified day 5 or 6 blastocysts does not increase the risk of birth defects compared with vitrified day 3 embryos. However, randomized control trials and follow-up studies of the long-term outcome of children born after blastocyst-stage transfers are needed to confirm the clinical safety of extending embryo culture to the blastocyst stage.

Hardarson T, Van Landuyt L, Jones G (2012) The blastocyst. Hum Reprod 27(suppl 1):i72–i91. https://doi.org/10.1093/humrep/des230 CrossRefPubMed

Dar S, Lazer T, Shah PS, Librach CL (2014) Neonatal outcomes among singleton births after blastocyst vs. cleavage stage embryo transfer: a systematic review and meta-analysis. Hum Reprod Update 20(3):439–448. https://doi.org/10.1093/humupd/dmu001 CrossRefPubMed

Chambers GM, Chughtai AA, Farquhar CM, Wang YA (2015) Risk of preterm birth after blastocyst embryo transfer: a large population study using contemporary registry data from Australia and New Zealand. Fertil Steril 104(4):997–1003. https://doi.org/10.1016/j.fertnstert.2015.07.1130 CrossRefPubMed

Osamu I, Ryuichiro A, Akira K, Atsuo I, Hidekazu S, David AG (2014) Impact of frozen-thawed single-blastocyst transfer on maternal and neonatal outcome: an analysis of 277,042 single-embryo transfer cycles from 2008 to 2010 in Japan. Fertil Steril 101(1):128–133. https://doi.org/10.1016/j.fertnstert.2013.09.025 CrossRef

Bengt KL, Orvar FM, Anna L, Emma N, Karl-G Sta N, Petra Otterbla O (2010) Blastocyst vs. cleavage stage transfer in in vitro fertilization: differences in neonatal outcome?. Fertil Steril 94(5):1680–1683. https://doi.org/10.1016/j.fertnstert.2009.12.027 CrossRef

Dar S, Librach C, Gunby J, Bissonnette F, Cowan L (2013) Increased risk of preterm birth in singleton pregnancies after blastocyst vs. day 3 embryo transfer: canadian ART Register (CARTR) analysis. Hum Reprod 28(4):924–928CrossRefPubMed

Chen H, Wang Y, Lyu Q, Ai A, Fu Y, Tian H, Cai R, Hong Q, Chen Q, Shoham Z, Kuang Y (2015) Comparison of live-birth defects after luteal-phase ovarian stimulation vs. conventional ovarian stimulation for in vitro fertilization and vitrified embryo transfer cycles. Fertil Steril 103(5):1194–1201. https://doi.org/10.1016/j.fertnstert.2015.02.020 CrossRefPubMed

Davies MJ, Rumbold AR, Marino JL, Willson K, Giles LC, Whitrow MJ, Scheil W, Moran LJ, Thompson JG, Lane M, Moore VM (2017) Maternal factors and the risk of birth defects after IVF and ICSI: a whole of population cohort study. BJOG 124(10):1537–1544CrossRefPubMed

Boulet SL, Kirby RS, Reefhuis J, Zhang Y, Sunderam S, Cohen B, Bernson D, Copeland G, Bailey MA, Jamieson MA, Jamieson DJ, Kissin DM (2016) Assisted reproductive technology and birth defects among liveborn infants in Florida, Massachusetts, and Michigan, 2000–2010. JAMA Pediatr 170(6):e154934CrossRefPubMedPubMedCentral

10.

Simpson JL (2014) Birth defects and assisted reproductive technologies. Semin Fetal Neonatal Med 19(3):177–182CrossRefPubMed

11.

Yan J, Huang G, Sun Y, Zhao X, Chen S, Zou S, Hao C, Quan S, Chen ZJ (2011) Birth defects after assisted reproductive tech -nologies in China: analysis of 15,405 ofspring in seven centers (2004–2008). Fertil Steril 95(1):458–460. https://doi.org/10.1016/j.fertnstert.2010.08.024 CrossRefPubMed

12.

Shi W, Xue X, Zhang S, Zhao W, Liu S, Zhou H, Wang M, Shi J (2012) Perinatal and neonatal outcomes of 494 babies delivered from 972 vitrifed embryo transfers. Fertil Steril 97(6):1338–1342. https://doi.org/10.1016/j.fertnstert.2012.02.051 CrossRefPubMed

13.

Belva F, Bonduelle M, Roelants M, Verheyen G, Van Landuyt L (2016) Neonatal health including congenital malformation risk of 1072 children born after vitrifed embryo transfer. Hum Reprod 31(7):1610–1620. https://doi.org/10.1093/humrep/dew103 CrossRefPubMed

14.

Kato O, Kawasaki N, Bodri D, Kuroda T, Kawachiya S, Kato K, Takehara Y (2012) Neonatal outcome and birth defects in 6623 singletons born following minimal ovarian stimulation and vitrified vs. fresh single embryo transfer. Eur J Obstet Gynecol Reprod Biol 161(1):46–50CrossRefPubMed

15.

Glujovsky D, Farquhar C (2016) Cleavage-stage or blastocyst transfer: what are the benefits and harms? Fertil Steril 106(2):244–250. https://doi.org/10.1016/j.fertnstert.2016.06.029 CrossRefPubMed

16.

PCOT Technology (2013) Blastocyst culture and transfer in clinical-assisted reproduction: a committee opinion. Fertil Steril 99(3):667CrossRef

17.

Papanikolaou EG, Kolibianakis EM, Tournaye H, Venetis CA, Fatemi H, Tarlatzis B, Devroey P (2008) Live birth rates after transfer of equal number of blastocysts or cleavage-stage embryos in IVF. A systematic review and meta-analysis. Hum Reprod 23(1):91–99. https://doi.org/10.1093/humrep/dem339 CrossRefPubMed

18.

Papanikolaou EG, Camus M, Kolibianakis EM, Van Landuyt L, Van Steirteghem A, Devroey P (2006) In vitro fertilization with single blastocyst-stage vs. single cleavage-stage embryos. New Engl J Med 354(11):1139–1146. https://doi.org/10.1056/NEJMoa053524 CrossRefPubMed

19.

Embryologist DB, Proctor M, Johnson N, Olive D (2002) Cleavage stage vs. blastocyst stage embryo transfer in assisted conception. Cochrane Database Syst Rev 7(2):D2118. https://doi.org/10.1002/14651858.CD002118 CrossRef

20.

Maheshwari A, Hamilton M, Bhattacharya S (2016) Should we be promoting embryo transfer at blastocyst stage? Reprod Biomed Online 32(2):142–146CrossRefPubMed

21.

Lonergan P, Rizos D, Gutierrez-Adan A, Fair T, Boland MP (2003) Effect of culture environment on embryo quality and gene expression—experience from animal studies. Reprod Biomed Online 7(6):657–663CrossRefPubMed

22.

Calle A, Fernandez-Gonzalez R, Ramos-Ibeas P, Laguna-Barraza R, Perez-Cerezales S, Bermejo-Alvarez P, Ramirez MA, Gutierrez-Adan A (2012) Long-term and transgenerational effects of in vitro culture on mouse embryos. Theriogenology 77(4):785–793. https://doi.org/10.1016/j.theriogenology.2011.07.016 CrossRefPubMed

23.

Katsuhiko T, Tetsunori M, Tetsuya G, Chikahiro O (2005) Perinatal outcome of blastocyst transfer with vitrification using cryoloop: a 4-year follow-up study. Fertil Steril 84(1):88–92. https://doi.org/10.1016/j.fertnstert.2004.12.051 CrossRef

24.

Wikland M, Hardarson T, Hillensjö T, Westin C, Westlander G, Wood M, Wennerholm UB (2010) Obstetric outcomes after transfer of vitrified blastocysts. Hum Reprod 25(7):1699CrossRefPubMed

25.

Van LL, Stoop D, Verheyen G, Verpoest W, Camus M, Van DVH, Devroey P, Van DAE (2011) Outcome of closed blastocyst vitrification in relation to blastocyst quality: evaluation of 759 warming cycles in a single-embryo transfer policy. Hum Reprod 26(3):527–534CrossRef

26.

Rama RG, Jaya PG, Murali KK, Madan K (2009) Neonatal outcome after vitrified day 3 embryo transfers: a preliminary study. Fertil Steril 92(1):143–148. https://doi.org/10.1016/j.fertnstert.2008.05.014 CrossRef

27.

Liu SY, Teng B, Fu J, Li X, Zheng Y, Sun XX (2013) Obstetric and neonatal outcomes after transfer of vitrified early cleavage embryos. Hum Reprod 28(8):2093–2100. https://doi.org/10.1093/humrep/det104 CrossRefPubMed

28.

Samadirad B, Khamnian Z, Hosseini MB, Dastgiri S (2012) Congenital anomalies and termination of pregnancy in Iran. J Pregnancy 2012:574513. https://doi.org/10.1155/2012/574513 CrossRefPubMedPubMedCentral

29.

Svensson E, Ehrenstein V, Norgaard M, Bakketeig LS, Rothman KJ, Sorensen HT, Pedersen L (2014) Estimating the proportion of all observed birth defects occurring in pregnancies terminated by a second-trimester abortion. Epidemiology 25(6):866–871. https://doi.org/10.1097/EDE.0000000000000163 CrossRefPubMed

30.

Hackshaw A, Rodeck C, Boniface S (2011) Maternal smoking in pregnancy and birth defects: a systematic review based on 173 687 malformed cases and 11.7 million controls. Hum Reprod Update 17(5):589–604. https://doi.org/10.1093/humupd/dmr022 CrossRefPubMedPubMedCentral

31.

Deng C, Yi L, Mu Y, Zhu J, Qin Y, Fan X, Wang Y, Li Q, Dai L (2015) Recent trends in the birth prevalence of down syndrome in China: impact of prenatal diagnosis and subsequent terminations. Prenat Diagn 35(4):311–318. https://doi.org/10.1002/pd.4516 CrossRefPubMed

32.

Rocheleau CM, Bertke SJ, Lawson CC, Romitti PA, Sanderson WT, Malik S, Lupo PJ, Desrosiers TA, Bell E, Druschel C, Correa A, Reefhuis J (2015) Maternal occupational pesticide exposure and risk of congenital heart defects in the National Birth Defects Prevention Study. Birth Defects Res A Clin Mol Teratol 103(10):823–833. https://doi.org/10.1002/bdra.2335 CrossRefPubMedPubMedCentral

Titel: The risk of birth defects among children born after vitrified blastocyst transfers and those born after fresh and vitrified cleavage-stage embryo transfers
verfasst von: Qianqian Zhu
Ningling Wang
Bian Wang
Yun Wang
Yanping Kuang
Publikationsdatum: 23.08.2018
Verlag: Springer Berlin Heidelberg
Erschienen in: Archives of Gynecology and Obstetrics / Ausgabe 4/2018
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI: https://doi.org/10.1007/s00404-018-4870-x

Neu im Fachgebiet Gynäkologie und Geburtshilfe

23.04.2024 | Medikamente in Schwangerschaft und Stillzeit | Nachrichten

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

The risk of birth defects among children born after vitrified blastocyst transfers and those born after fresh and vitrified cleavage-stage embryo transfers

Abstract

Purpose

Methods

Results

Conclusions

Neu im Fachgebiet Gynäkologie und Geburtshilfe

ICI-Therapie in der Schwangerschaft wird gut toleriert

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

Update Gynäkologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2018

ESHRE–ESGE versus ASRM classification in the diagnosis of septate uterus: a retrospective study

Hyperthermic intraperitoneal chemotherapy (HIPEC) for ovarian cancer: a “useless intraoperative fever” or the next hot voice in the surgical management of the “silent killer”?

FTO, GCKR, CDKAL1 and CDKN2A/B gene polymorphisms and the risk of gestational diabetes mellitus: a meta-analysis

Birthweight and large for gestational age trends in non-diabetic women with three consecutive term deliveries

Adverse effect of paternal hepatitis B virus infection on clinical pregnancy after frozen–thawed embryo transfer

Myo-inositol supplementation reduces the amount of gonadotropins and length of ovarian stimulation in women undergoing IVF: a systematic review and meta-analysis of randomized controlled trials

Neu im Fachgebiet Gynäkologie und Geburtshilfe

ICI-Therapie in der Schwangerschaft wird gut toleriert

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

Update Gynäkologie